Rheumatoid Arthritis
Conditions
Brief summary
The overall goal is to improve shared decision-making (SDM) about treatment options and thereby enhance disease outcomes and health-related quality of life (HRQOL) for patients with rheumatoid arthritis (RA). The objective of this study is to engage patients in using the ArthritisPower application on a weekly basis during the time between clinic appointments for collection of data on self-reported disease activity and patient-reported outcomes (PROs), and to display the data using an iPad to the patients and their rheumatology health care providers (HCPs) at the point of care for SDM.
Interventions
BEHAVIORALMobile Health App
ArthritisPower App
Sponsors
Mayo Clinic
Study design
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
1. Age ≥ 18 years. 2. Fulfillment of the ACR/EULAR 2010 classification criteria for RA \[9\]. 3. Moderate or high disease activity, according to CDAI ≥ 10, at the baseline visit. 4. Intent to modify DMARD therapy (i.e., adding a DMARD, switching to a new DMARD, or changing DMARD dosage) by the patient and HCP.
Exclusion criteria
1. Current or previous use of ArthritisPower™ by the patient. 2. Lack of access to an ArthritisPower™ compatible device (e.g., smartphone, tablet, or computer) 3. Inability or unwillingness to participate with using the ArthritisPower™ app for this study
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| - Determine the impact of ArthritisPower™ integration into the clinical evaluation of patients with RA on the primary endpoint of clinical improvement as defined by the continuous change in the Clinical Disease Activity Index (CDAI) (1). | 24 months |
Countries
United States
Outcome results
None listed